Novo Nordisk Sues Pharmacy For Selling Compounded Drugs Containing Semaglutide

(May 31, 2024, 2:09 PM EDT) -- HOUSTON — Novo Nordisk Inc. on May 30 filed a complaint in a Texas federal court, asking that a pharmacy be enjoined from “selling misbranded injectable, non-FDA approved drugs that claim to contain semaglutide.”...

Attached Documents

Related Sections